Sun Pharmaceutical Industries Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 111,001.4 million compared to INR 98,141.7 million a year ago. Revenue was INR 114,148.5 million compared to INR 102,955.7 million a year ago. Net income was INR 21,660.1 million compared to INR 20,588 million a year ago. Basic earnings per share from continuing operations was INR 9 compared to INR 8.6 a year ago. Diluted earnings per share from continuing operations was INR 9 compared to INR 8.6 a year ago.
For the nine months, sales was INR 325,533 million compared to INR 290,403.4 million a year ago. Revenue was INR 332,162.5 million compared to INR 300,156.5 million a year ago. Net income was INR 64,891.1 million compared to INR 55,499.8 million a year ago. Basic earnings per share from continuing operations was INR 27 compared to INR 23.1 a year ago. Diluted earnings per share from continuing operations was INR 27 compared to INR 23.1 a year ago.